A modern clinic for at-home treatments
(857) 240-1080
! Not medical advice. Consult a doctor.







Loteprednol etabonate is a corticosteroid known for its anti-inflammatory properties, primarily used in ophthalmic formulations under brand names such as Alrex and Lotemax.
Drug Category
Uses of Loteprednol Etabonate
Conditions Treated
Why settle for temporary relief? Try immunotherapy for lasting results!
Am I eligible?
Loteprednol etabonate, commonly marketed as Alrex and Lotemax, is a corticosteroid medication primarily used in ophthalmology. It is implemented to manage conditions and symptoms associated with inflammatory processes of the eye.
Key Conditions Treated
Benefits of Loteprednol Etabonate
Find out if immunotherapy is right for you

Benefits of Loteprednol Etabonate (Alrex, Lotemax)

Loteprednol etabonate (Alrex, Lotemax) is a corticosteroid medication used to treat inflammation in the eyes. As with any medication, there are potential side effects and safety precautions that should be considered to ensure its safe use.
Common Side Effects
Serious Side Effects
Safety Precautions
A safer solution to allergies: try immunotherapy today!

Understanding the benefits of immunotherapy over Loteprednol etabonate for treating allergies requires a deep dive into their mechanisms and outcomes. Below are the profound advantages of choosing immunotherapy.
Long-term Relief
Reduction in Medication Dependence
Comprehensive Allergy Control
Fewer Side Effects
Potential for Allergy Prevention
Holistic Health Improvement

Treatment prescribed
by clinician


Clinicaly made allergen extracts are customized for your allergies


Your immune system gets desensitized to allergens, giving you long-term relief.
Medical disclaimer.
This page is for educational purposes only and is not medical advice, diagnosis, or treatment. It is not a substitute for consultation with a licensed healthcare provider. Always talk to a qualified clinician before starting, stopping, or changing any allergy treatment. Outcomes from allergy immunotherapy vary from patient to patient. Response rates, symptom-reduction percentages, timelines, and pricing referenced on this page are based on peer-reviewed literature, clinical guidelines, and current Curex membership plans at the time of review - they are population averages or current offers, not a prediction of individual results, and are subject to change. Eligibility for any treatment is determined by a licensed clinician on a case-by-case basis. Cntent reviewed by a licensed clinician. References to third-party products, brand names, or competitor services are for educational comparison only and do not imply endorsement.